[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Ginefiv\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":119},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,56,92],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":34,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":44,"lastUpdatePostDateStruct":45,"startDateStruct":48,"completionDateStruct":50,"leadSponsor":52,"locationsCount":55},"100621793","effect-of-daily-intake-of-gazpacho-on-semen-quality-and-oxidative-stress-100621793",false,"NCT07375238","Effect of Daily Intake of Gazpacho on Semen Quality and Oxidative Stress","Effect of Daily Intake of Gazpacho on Semen Quality and Oxidative Stress in Men With Altered Semen Parameters: A Randomized Controlled Study","G-OXSEM","Inclusion Criteria:\n\n* Men aged 18 to 45 years\n* Andrological profile including altered semen parameters such as oligozoospermia, asthenozoospermia and\u002For teratozoospermia (O±A±T)\n* No clinical indication for sperm DNA fragmentation testing or advanced sperm selection techniques\n* Willingness and ability to comply with the study protocol, including adherence to a standardized Mediterranean diet\n* Signed and dated written informed consent form\n\nExclusion Criteria:\n\n* Use of antioxidant supplements during the three months prior to study start.\n* Active smokers or men who have stopped smoking within the last three months.\n* Diagnosis of azoospermia, leucocytospermia or necrozoospermia.\n* Presence of severe systemic diseases or chronic conditions that could interfere with semen quality or adherence to the study.\n* Known allergy or intolerance to any ingredient of the gazpacho used in the study.\n* Any medical, psychological or social condition that, in the investigator's judgement, could compromise the subject's ability to participate fully or comply with the protocol requirements.\n* Simultaneous participation in another clinical study.","MALE","18 Years","45 Years",{"count":21,"type":22},80,"ESTIMATED","INTERVENTIONAL",[25],"NA","The goal of this clinical trial is to learn whether drinking a daily serving of gazpacho can improve semen quality in men with reduced sperm quality. The study will also examine how this dietary intervention affects oxidative stress and whether it is well tolerated.\n\nThe main questions this study aims to answer are:\n\n* Does daily consumption of gazpacho improve semen quality in men with altered semen parameters?\n* Does this dietary intervention affect levels of oxidative stress in semen?\n* Is daily gazpacho intake feasible and well tolerated as part of a Mediterranean diet?\n\nResearchers will compare a Mediterranean diet plus daily gazpacho intake with a Mediterranean diet alone to determine whether adding gazpacho provides additional benefits for male reproductive health.\n\nParticipants will:\n\n* Follow a standardized Mediterranean diet for 12 weeks\n* Drink 330 mL of gazpacho every day or follow the diet without gazpacho\n* Provide semen samples at the start of the study and after 12 weeks\n* Complete a short diary to record adherence to the dietary intervention\n* Be followed for up to 18 months to record reproductive outcomes",[28,29,30,31,32,33],"Male Infertility","Oxidative Stress","Subfertility","Oligozoospermia","Asthenozoospermia","Teratozoospermia",[35,36,37,38,39,40,41,42],"Mediterranean diet","Gazpacho","sperm quality","Male infertility","Altered semen parameters","oxidative stress","OxiSperm II","Randomized trial","RECRUITING","2026-03-11",{"date":46,"type":47},"2026-03-13","ACTUAL",{"date":49,"type":47},"2026-03-02",{"date":51,"type":22},"2029-09-01",{"name":53,"class":54},"Ginefiv","OTHER",1,{"id":57,"slug":58,"hasResults":11,"nctId":59,"briefTitle":60,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":63,"sex":64,"minAge":18,"maxAge":65,"enrollmentInfo":66,"targetDuration":4,"studyType":23,"phases":68,"briefSummary":70,"conditions":71,"keywords":79,"overallStatus":84,"whyStopped":4,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":88,"completionDateStruct":89,"leadSponsor":91,"locationsCount":4},"100565054","phase-4-protocol-with-progestin-primed-ovarian-stimulation-ppos-from-the-beginning-of-stimulation-versus-protocol-with-gnrh-antagonists-for-ovarian-stimulation-in-patients-undergoing-duostim-with-embryo-accumulation-for-pgt-a-100565054","NCT06637189","Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.","PPDUO","Inclusion Criteria:\n\n* Regular menstrual cycles between 21 and 35 days, inclusive.\n* Indication of IVF with PGT-A.\n* Both ovaries present.\n* Ability to participate and complete the study.\n* Give and sign the consent to participate in the study.\n\nExclusion Criteria:\n\n* Endometriosis grade III\u002FIV\n* Concurrent participation in another study",true,"FEMALE","43 Years",{"count":67,"type":22},144,[69],"PHASE4","The PPOS protocol (Progestin-primed Ovarian Stimulation) involves avoiding ovulation during ovarian stimulation with progesterone. It is a reliable and safe protocol that has been widely used in recent years for in vitro fertilization, as it reduces the number of injections needed during controlled ovarian stimulation and is more cost-effective for patients.\n\nThe aim of this study is to compare two methods of ovarian stimulation for in vitro fertilization: the PPOS protocol (Group A) and the conventional protocol with injected antagonists (Group B). The goal is to determine whether both methods are equally effective in obtaining euploid embryos in the context of double ovarian stimulation.",[72,73,74,75,76,77,78],"Stimulation in the Ovary","Embryo","Oocyte","Oocyte Retrieval","Fertilization in Vitro","Blastocyst","PGT-A",[80,81,82,83,78],"duostim","ovarian stimulation","progesterone","GnRH antagonists","NOT_YET_RECRUITING","2024-10-10",{"date":87,"type":47},"2024-10-15",{"date":87,"type":22},{"date":90,"type":22},"2025-12-31",{"name":53,"class":54},{"id":93,"slug":94,"hasResults":11,"nctId":95,"briefTitle":96,"officialTitle":97,"acronym":4,"eligibilityCriteria":98,"healthyVolunteers":11,"sex":64,"minAge":18,"maxAge":65,"enrollmentInfo":99,"targetDuration":4,"studyType":23,"phases":101,"briefSummary":102,"conditions":103,"keywords":105,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":110,"lastUpdatePostDateStruct":111,"startDateStruct":113,"completionDateStruct":115,"leadSponsor":117,"locationsCount":118},"100540648","the-impact-of-personalized-prognostic-counseling-on-ivf-patients-experience-and-treatment-utilization-100540648","NCT06319573","The Impact of Personalized Prognostic Counseling on IVF Patient's Experience and Treatment Utilization","Evaluation of in Vitro Fertilisation Patients' Experience With a Personalized Prognostic Counseling Strategy and Its Impact on Treatment Utilization and Discontinuation","Inclusion Criteria:\n\n* Patients between 18-43 in age and their healthcare providers have determined that IVF treatment using the patients' own eggs is indicated.\n\nExclusion Criteria:specific to this study only (these are not contraindications to using the Univfy® PreIVF Report):\n\n* Same sex couples\n* Patients undergoing DuoStim and\u002For PGT-M\u002F-SR\n* Patients considering egg freezing rather than IVF\n* Patients considering the use of donor eggs or gestational carrier\n\nPatients with contraindications to receiving the Univfy® PreIVF Report For Patients Under 40 Using Their Own Eggs. Those contraindications are:\n\n* Patients who are perimenopausal or menopausal\n* Patients who have very poor IVF results in the past, including:\n* extremely poor oocyte\u002Fembryo quality, no embryos to transfer,\n* no euploid embryos on PGT-A, no blastocysts in extended culture",{"count":100,"type":22},366,[25],"This study will be conducted in two phases. In the first phase, research subjects will be assigned to receive standard counseling. In the second phase, research subjects will receive Univfy counseling.",[104],"Infertility",[106,107,108,109],"Infertile Women Undergoing IVF or ICSI","Fertility Issues","Machine Learning","Counseling","2024-08-21",{"date":112,"type":47},"2024-08-22",{"date":114,"type":47},"2024-03-19",{"date":116,"type":22},"2026-02-28",{"name":53,"class":54},2,""]